ASX Share rice
Sun 09 Aug 2020 - 06:07:pm (Sydney)

VTI Share Price


VTI Company Information


Visioneering Technologies, Inc




Medical Devices


10745 Westside Way Alpharetta GA United States 30009



CEO & Exec. Director:

Dr. Stephen Snowdy

Chief Financial Officer:

Mr. Brian D. Lane CPA

Sr. VP of Sales & Marketing:

Mr. Tony Sommer Jr.

Founder & Medical Adviser:

Dr. Richard A. Griffin

Company Sec.:

Ms. Leanne Ralph A.C.I.S., BBus, ACIS, AAICD

Company Overview:

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses. The company offers NaturalVue, a contact lense for adults with presbyopia and children with myopia. It operates in the United States, Australia, New Zealand, Europe, Hong Kong, and Singapore. The company was founded in 2008 and is headquartered in Alpharetta, Georgia.

VTI Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


VTI CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Change To Inventory:


Change To Account Receivables:


Capital Expenditures:


VTI Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Interest Expense:


Income Tax Expense:


Total Revenue:


Total Operating Expenses:


Cost Of Revenue:


VTI Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Retained Earnings:


Other Assets:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Long-Term Debt:


Net Receivables:


Short-Term Investments:




Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities (Other):


Non Current Liabilities Total:


VTI Share Price History

VTI News

04 Aug, 2020
LOS ANGELES, CA / ACCESSWIRE / August 3, 2020 / The SNN Network Virtual Conference will take place on August 3rd \\- 6th, 2020, where 49 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.
06 Feb, 2020
US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses, Visioneering Technologies, Inc. (ASX: VTI) (‘Visioneering’ or ‘The Company’) presented at the Global Specialty Lens Symposium (GSLS) an update of clinical data with mature presbyopes, those patients with > +1.75 ADD power and over 55 years of age.
29 Jan, 2020
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
30 Oct, 2019
Taking the occasional loss comes part and parcel with investing on the stock market. Unfortunately, shareholders of...
25 Oct, 2019
US-based medical device company and manufacturer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses Visioneering Technologies, Inc (VTI.AX) (‘Visioneering’ or ‘the Company’) will be presenting the science behind the NaturalVue® Multifocal (etafilcon A) 1 Day Contact Lens with a poster on Friday, October 25. The poster, entitled “Instantaneous Power Profiles vs Sagittal Power Profiles of Various Center Distance Multifocal Lenses” was authored by Rosa Lee, MS, Peg Achenbach, OD, FAAO, Jim Schwiegerling, PhD.
15 Oct, 2019
Craig Johnson joined Visioneering Technologies, Inc. in the role of Quality Specialist, based in their Alpharetta, GA Headquarters. Johnson will be responsible for ongoing management of field quality activities including materials copy review administration and tracking, label inspection and control, sales team training, complaint handling and customer feedback. VTI is a global company dedicated to improving vision through a comprehensive product portfolio including the NaturalVue® brand of contact lenses and quality control is one of the most important aspects of the company’s responsibilities.